1. Home
  2. PLNT vs BPMC Comparison

PLNT vs BPMC Comparison

Compare PLNT & BPMC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PLNT
  • BPMC
  • Stock Information
  • Founded
  • PLNT 1992
  • BPMC 2008
  • Country
  • PLNT United States
  • BPMC United States
  • Employees
  • PLNT N/A
  • BPMC N/A
  • Industry
  • PLNT Hotels/Resorts
  • BPMC Biotechnology: Pharmaceutical Preparations
  • Sector
  • PLNT Consumer Discretionary
  • BPMC Health Care
  • Exchange
  • PLNT Nasdaq
  • BPMC Nasdaq
  • Market Cap
  • PLNT 8.1B
  • BPMC 8.3B
  • IPO Year
  • PLNT 2015
  • BPMC 2015
  • Fundamental
  • Price
  • PLNT $110.45
  • BPMC $129.32
  • Analyst Decision
  • PLNT Strong Buy
  • BPMC Buy
  • Analyst Count
  • PLNT 15
  • BPMC 20
  • Target Price
  • PLNT $106.60
  • BPMC $127.82
  • AVG Volume (30 Days)
  • PLNT 1.4M
  • BPMC 3.3M
  • Earning Date
  • PLNT 08-05-2025
  • BPMC 07-31-2025
  • Dividend Yield
  • PLNT N/A
  • BPMC N/A
  • EPS Growth
  • PLNT 21.55
  • BPMC N/A
  • EPS
  • PLNT 2.11
  • BPMC N/A
  • Revenue
  • PLNT $1,129,218,000.00
  • BPMC $562,121,000.00
  • Revenue This Year
  • PLNT $20.70
  • BPMC $44.46
  • Revenue Next Year
  • PLNT $10.29
  • BPMC $32.78
  • P/E Ratio
  • PLNT $52.29
  • BPMC N/A
  • Revenue Growth
  • PLNT 10.26
  • BPMC 99.19
  • 52 Week Low
  • PLNT $68.75
  • BPMC $73.04
  • 52 Week High
  • PLNT $110.95
  • BPMC $129.49
  • Technical
  • Relative Strength Index (RSI)
  • PLNT 61.90
  • BPMC 76.79
  • Support Level
  • PLNT $104.39
  • BPMC $128.06
  • Resistance Level
  • PLNT $108.36
  • BPMC $129.49
  • Average True Range (ATR)
  • PLNT 3.06
  • BPMC 0.27
  • MACD
  • PLNT -0.04
  • BPMC -0.97
  • Stochastic Oscillator
  • PLNT 93.15
  • BPMC 87.41

About PLNT Planet Fitness Inc.

Planet Fitness Inc is a franchisor and operator of fitness centers in the United States. The company's reportable segments are Franchise, Corporate-owned stores, and Equipment. Franchise segment includes operations related to its franchising business in the United States, Puerto Rico, Canada, Panama, Mexico and Australia, Corporate-owned stores segment includes operations with respect to all corporate-owned stores throughout the United States and Canada, and The Equipment segment includes the sale of equipment to franchisee-owned stores in the U.S. The firm generates a majority of its revenue from the Corporate-owned stores segment.

About BPMC Blueprint Medicines Corporation

Blueprint Medicines Corp is a biopharmaceutical company. It is developing medicines in the following focus areas; allergy, inflammation, oncology, and hematology. Its approved medicines, including Avyakit and Avyakyt, are given to patients living with systemic mastocytosis (SM) and PDGFRA Exon 18 mutant GIST in the U.S. and Europe. The company also has various other drug candidates in its pipeline such as BLU-808, BLU-222, BLU-956, and others that are being developed to treat mast cell diseases including SM and chronic urticaria, breast cancer, and other solid tumors. Geographically, it operates in the United States, which is its key revenue market, and Europe.

Share on Social Networks: